Investing
Bausch & Lomb’s stock soars 9% after earnings beat
Bausch & Lomb Corp.’s stock soared 10% early Wednesday after the eye-care company reported adjusted fourth-quarter profit that topped estimates and offered upbeat revenue guidance…
Your best advisor to finance and money management.
Explaining Finance is your one-stop website for the latest news, updates, and tips about finance.
Latest News
Why a Wall Street stock downgrade means more for your money than an upgrade
A fundamental imbalance exists between Wall Street “buys” and “sells.” For example, how should an investor interpret a recent upgrade…
SVB Bank’s Collapse Threatens Roku
For the first time in three years bears are going to try to take advantage of a bank panic. This…
Nio’s planned $1 billion convertible offering follows stretch of swelling losses
U.S.-listed shares of Nio Inc. were falling more than 5% in after-hours action Monday after the Chinese electric-vehicle company announced…
Starbucks might have a bigger China problem than Wall Street thinks
Starbucks Inc. might have bigger challenges in China than investors realize, according to one analyst. TD Cowen’s Andrew Charles sees…
Rocket Lab’s stock dives after latest launch ends in failure
Shares of Rocket Lab USA Inc. dove Tuesday toward their ninth loss in 10 sessions after the spacecraft and rocket…
Instacart IPO prices at $30 a share, but stock is indicated to open much higher
The grocery-delivery app Instacart priced its IPO at $30 a share, at the upper end of its expected range, raising…
Retailers compete to be first to hold holiday sales in a bid to spur flagging demand
Best Buy Co. Inc. said Tuesday it’s planning to start its annual holiday savings events in October this year instead…
Most large cryptocurrencies climb on Polygon, Dogecoin increases
Most large cryptocurrencies were up during morning trading on Tuesday, with Polygon MATICUSD, +2.68% seeing the biggest change, climbing 1.54%…
All Hit New 2023 Lows
The expectation that interest rates will continue higher and for longer than previously thought continues to hurt the price of…
We’re investing in bonds all wrong
Why do retirees, near-retirees and others seeking stability typically invest only in U.S. bonds — whether they be U.S. Treasury…
Three Things To Watch For In The Fed’s Upcoming September Decision
On September 20 at 2p.m. ET the Federal Reserve will announce its decision on interest rates. No change in rates…
IPO market braces for first tech unicorns in nearly two years
The initial public offering market, fresh off its biggest transaction of the year, is expected to welcome five deals this…
How The Fed Went From Doom To Boom (And What To Buy Next)
All year long, we’ve been waiting for our favorite high-yield investments, 8%+ yielding closed-end funds (CEFs), to jump, along with…
Huawei & Apple Sales Prove The Strength Of The China Consumer
Key News Asian equities were off on light volumes except for Hong Kong. India was closed for Ganesh Chaturthi, a…
Oil extends rise above $90-a-barrel to mark fresh highs for the year
Oil futures marked fresh highs for the year on Monday, after posting a third consecutive weekly climb on continued concerns…
Is The U.K. Market Ready To Go Ballistic?
The U.K. market is so painfully cheap it is now privately being described by fund managers as offering a generational…
Gold prices end at a more than 2-week high as September Fed meeting looms
Gold prices settled Monday at their highest in more than two weeks, finding some support from weakness in the U.S.…
BioCryst Pharmaceuticals Shares Rise 8% After Quebec’s Approval of Orladeyo
By Chris Wack BioCryst Pharmaceuticals shares were up 8% at $7.40 after the Institut national d'excellence en sante et services…